Ankumoni M. Dutta
Behali, AS 784184, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Arsenic Exposure Induces Cognitive Impairment in Mice with Increased Acetylcholinesterase Activity and Inflammation in the Cortex and Hippocampus: Implications for Alzheimer's Disease.
Journal: Current Alzheimer research
Published: March 18, 2025
Arsenic-induced mice model of Parkinson's disease: Revealing the neurotoxicity of arsenic through mitochondrial complexes inhibition and dopaminergic neurodegeneration in the substantia nigra region of brain.
Journal: Brain research
Published: September 17, 2024
Targeting of wnt signalling pathway by small bioactive molecules for the treatment of Alzheimer's disease.
Journal: In silico pharmacology
Published: October 25, 2023
Garcinia morella extract confers dopaminergic neuroprotection by mitigating mitochondrial dysfunctions and inflammation in mouse model of Parkinson's disease.
Journal: Metabolic brain disease
Published: February 16, 2022
Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson's disease: involvement of anti-inflammatory response.
Journal: Experimental brain research
Published: October 19, 2020
Natural Products and Their Therapeutic Effect on Autism Spectrum Disorder.
Journal: Advances in neurobiology
Published: February 02, 2020
Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer's Disease in Mice.
Journal: Bioconjugate chemistry
Published: September 26, 2019
Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeutics.
Journal: Neurochemistry international
Published: December 24, 2018
Garcinol, a multifaceted sword for the treatment of Parkinson's disease.
Journal: Neurochemistry international
Published: December 18, 2018
Garcinol, an effective monoamine oxidase-B inhibitor for the treatment of Parkinson's disease.
Journal: Medical hypotheses
Published: April 25, 2018
Accumulation of Cholesterol and Homocysteine in the Nigrostriatal Pathway of Brain Contributes to the Dopaminergic Neurodegeneration in Mice.
Journal: Neuroscience
Published: March 15, 2018
Last Updated: 09/26/2026